VS-5584
- Generic Name
- VS-5584
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H22N8O
- CAS Number
- 1246560-33-7
- Unique Ingredient Identifier
- W71J4X250V
- Background
VS-5584 has been used in trials studying the treatment of Lymphoma, Metastatic Cancer, and Non Hematologic Cancers.
- Associated Conditions
- -
- Associated Therapies
- -
Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2017-01-27
- Lead Sponsor
- Verastem, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT01991938
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸Tennessee Oncology, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath